TIM
SNDX icon

Thornburg Investment Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Thornburg Investment Management’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-130,746
Closed -$16.1M – 186
2025
Q1 		$16.1M Buy
130,746
+15,659
+14% +$221K 0.02% 157
2024
Q4 		$1.52M Sell
115,087
-1,725
-1% -$29.5K 0.02% 165
2024
Q3 		$2.25M Buy
+116,812
New +$2.41M 0.03% 167

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Thornburg Investment Management's SNDX Position: Q2 2025 in Review

Thornburg Investment Management sold out of Syndax Pharmaceuticals (SNDX) in Q2 2025, closing a stake of 130,746 shares — an estimated $16.1M sold.

Thornburg Investment Management first reported a position in SNDX in Q3 2024 and held it in 3 quarters. The position peaked at $16.1M in Q1 2025. 216 funds tracked by Wall St. Rank hold SNDX as of Q2 2025.

  • Thornburg Investment Management reported no remaining Syndax Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Thornburg Investment Management sold 130,746 Syndax Pharmaceuticals shares in Q2 2025, an estimated $16.1M.
  • Thornburg Investment Management first reported a position in Syndax Pharmaceuticals in Q3 2024 and held it in 3 quarters.
  • Thornburg Investment Management's Syndax Pharmaceuticals position peaked at $16.1M in Q1 2025.
  • 216 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2025.

Based on Thornburg Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.